A phase II study of oxaliplatin and gemcitabine followed by radiation therapy in the management of mixed mullerian tumors of the uterus.

Trial Profile

A phase II study of oxaliplatin and gemcitabine followed by radiation therapy in the management of mixed mullerian tumors of the uterus.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary)
  • Indications Uterine cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Mar 2016 Status changed from active, no longer recruiting to completed.
    • 26 Aug 2013 Planned end date changed from 1 Aug 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
    • 03 Dec 2012 Planned end date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top